Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ: COSM) has announced a significant expansion of its investment in digital assets, purchasing $600,000 worth of Bitcoin. This strategic move has increased the company's total holdings in digital assets to $3.1 million, which encompasses both Bitcoin and Ethereum. CEO Greg Siokas emphasized the firm’s view of digital assets as a promising investment class with considerable upside potential. This decision aligns with Cosmos Health's disciplined treasury strategy aimed at diversifying its balance sheet while preserving financial flexibility.
Siokas also mentioned that the growing position in these digital assets serves as a mechanism to address what he perceives as a market undervaluation of the company. By maintaining these digital assets, Cosmos Health can potentially unlock additional value for shareholders, using them as a financial buffer or monetizing them to support operations and enhance shareholder returns.
Founded in 2009, Cosmos Health is a diversified global healthcare company, integrating pharmaceutical and nutraceutical businesses. The company boasts a portfolio of well-recognized brands and has established a robust presence across Europe and North America. Among its operations, Cosmos Health manufactures a range of healthcare products through its subsidiary, Cana Laboratories S.A., and is actively involved in research partnerships targeting health issues such as obesity, diabetes, and cancer. Additionally, the company has ventured into telehealth services through its acquisition of ZipDoctor, Inc.
As Cosmos Health pursues its growth trajectory in the healthcare sector, the allocation of resources toward digital assets represents a strategic enhancement aimed at bolstering its financial standing and market position.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ:COSM) has recently made headlines with its strategic acquisition of $600,000 in Bitcoin, raising its total digital asset holdings to approximately $3.1 million. This move aligns with the broader trend of traditional companies exploring cryptocurrency as a viable asset class amid market fluctuations and inflation concerns.
Investors should adopt a balanced perspective regarding this development. On one hand, Cosmos Health’s decision reflects a forward-thinking approach to corporate treasury management. CEO Greg Siokas emphasizes the dual purpose of enhancing balance sheet diversification and providing financial flexibility. By including digital assets in its investment portfolio, the company can potentially mitigate risks associated with currency volatility and leverage the growing acceptance of cryptocurrencies in mainstream finance.
However, it is essential to consider the inherent volatility and risks associated with digital assets. The cryptocurrency market remains unpredictable, and while Bitcoin has demonstrated robustness over time, significant price fluctuations can pose challenges for companies relying on these assets for liquidity and operational stability. Thus, maintaining due diligence is crucial for investors evaluating the longevity and practicality of Cosmos Health’s strategy.
Moreover, the context of Cosmos Health’s core operations in the healthcare sector remains critical. The company boasts a diversified portfolio of pharmaceuticals, nutraceuticals, and innovative R&D initiatives, which can drive sustainable growth. Investors should weigh the potential of digital asset holdings against the fundamental strengths and risks associated with the healthcare sector and the broader economic climate, particularly the impacts of external factors like geopolitical tensions.
In summary, while Cosmos Health’s investment in Bitcoin showcases an exciting diversification tactic, investors should consider both the opportunities and risks it brings, ensuring that any investment in COSM aligns with their overall strategy and risk tolerance. Keeping a close watch on market trends and the company's performance in its primary business operations will be paramount.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of Bitcoin as part of its ongoing digital assets treasury initiative.
Following this purchase, Cosmos Health’s total investment in digital assets has reached $3.1 million, reflecting the combined value of its holdings in Bitcoin and Ethereum.
Greg Siokas, CEO of Cosmos Health, stated: "We continue to view select digital assets as an attractive asset class with strong upside potential. Our growing position in Bitcoin and Ethereum reflects a disciplined treasury strategy designed to enhance balance sheet diversification while maintaining financial flexibility. As we continue to expand our core healthcare operations and execute on our broader growth strategy, we believe selectively allocating capital to digital assets can complement our balance sheet and create additional value for shareholders.
At the same time, if the market does not fully recognize the intrinsic value of our Company, these digital assets provide additional financial flexibility and may be monetized to help address the current discount to book value and support initiatives that enhance shareholder value.”
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Holdings Inc. COSM plan to leverage its $3.1 million investment in digital assets to support its growth strategy in traditional healthcare operations and R&D initiatives?
Given Cosmos Holdings Inc. COSM's entry into the telehealth market with ZipDoctor, what synergies are anticipated between this acquisition and the company's digital asset investments?
In light of external market conditions, how does Cosmos Holdings Inc. COSM ensure that its digital asset strategy remains aligned with its financial flexibility and shareholder value objectives?
What risk management strategies does Cosmos Holdings Inc. COSM have in place to mitigate potential volatility associated with its investments in Bitcoin and Ethereum amid changing market conditions?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
-3.36% G/L:
$0.2505 Last:
367,675 Volume:
$0.264 Open:
